Ironwood Pharmaceuticals IRWD Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's operating lease ROU assets?
- Ironwood Pharmaceuticals (IRWD) reported operating lease ROU assets of $8.9M in Q1 2026.
- How has Ironwood Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Ironwood Pharmaceuticals's operating lease ROU assets decreased by 16.2% year-over-year, from $10.62M to $8.9M.
- What is the long-term trend for Ironwood Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's operating lease ROU assets has grown at a -10.8% compound annual growth rate (CAGR), from $16.58M to $9.34M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.